Endocrine Abstracts

C-peptide is a marker of pancreatic beta cell function and is used to investigate hypoglycaemic disorders and aid diabetes classification. An international consensus report (ADA/EASD) on the management of type 1 diabetes recommends C-peptide (with concurrent glucose) measurement, in individuals 3 years after diagnosis where there is uncertainty about diabetes classification. We conducted a retrospective audit of C-peptide testing among adult patients in Galway University Hospi...